Provided By Globe Newswire
Last update: Feb 27, 2023
SEATTLE, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming 43rd Annual Cowen Healthcare Conference in Boston, Masssachusetts.
NASDAQ:ADPT (5/13/2025, 2:12:56 PM)
9.38
-0.13 (-1.37%)
Find more stocks in the Stock Screener
ADAPTIVE BIOTECHNOLOGIES (ADPT) meets Minervini’s Trend Template with strong technicals and high growth momentum, making it a candidate for growth investors. The stock scores a perfect 10 on technical health but may need consolidation before an optimal entry.
Intrigued by the market activity one hour before the close of the markets on Friday? Uncover the key winners and losers of today's session in our insightful analysis.
Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session.
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.